Evidence map›Paper›PMID 23566162›Full record

ArticleLeukemia & lymphoma2014

A novel three-dimensional stromal-based model for in vitro chemotherapy sensitivity testing of leukemia cells.

Omar S Aljitawi, Dandan Li, Yinghua Xiao, Da Zhang, Karthik Ramachandran, Lisa Stehno-Bittel, Peter Van Veldhuizen, Tara L Lin, Suman Kambhampati, Rama Garimella

Open access · greenAbstract read
In one paragraph

Article in Leukemia & lymphoma, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 111 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. PeerJ · 2024
    Article
  13. Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Omar S AljitawiHematology/Oncology, Blood and Marrow Transplant Program.
Dandan Li
Yinghua Xiao
Da Zhang
Karthik Ramachandran
Lisa Stehno-Bittel
Peter Van Veldhuizen
Tara L Lin
Suman Kambhampati
Rama Garimella
European Society for Blood and Marrow Transplantation · FRPalmetto Hematology Oncology · USAcademy of Nutrition and Dietetics · US

Funding

Chemotherapy resistance in ALL: role of the bone marrow microenvironmentK23CA158146 · NCI · UNIVERSITY OF KANSAS MEDICAL CENTER · PI LIN, TARA · 2012 to 2015
$700k
NCI NIH HHS K23 CA158146
6 · The paper itself

Abstract

The disparate response of leukemia cells to chemotherapy in vivo, compared to in vitro, is partly related to the interaction of leukemic cells and the three-dimensional bone marrow stromal microenvironment. We investigated the effects of chemotherapy agents on leukemic cell lines co-cultured with human bone marrow mesenchymal stem cells (hu-BM-MSCs) in a three-dimensional model (3D). Comparison was made to leukemic cells treated in suspension, or grown on a hu-BM-MSC monolayer (2D conditions). We demonstrated that leukemic cells cultured in 3D were more resistant to drug-induced apoptosis compared to cells cultured in 2D or in suspension. We also demonstrated significant differences in leukemic cell response to chemotherapy using different leukemic cell lines cultured in 3D. We suggest that the differential responses to chemotherapy in 3D may be related to the expression of N-cadherin in the co-culture system. This unique model provides an opportunity to study leukemic cell responses to chemotherapy in 3D.

Indexed as

Models, BiologicalAntineoplastic AgentsApoptosisBone Marrow CellsCadherinsCell Culture TechniquesCell Line, TumorCell ProliferationCells, CulturedCoculture TechniquesCytarabineDose-Response Relationship, DrugDoxorubicinFlow CytometryHL-60 CellsHumansAntineoplastic AgentsCadherinsCytarabineDoxorubicinKi-67 Antigen

Identifiers

PMID23566162
PMCPMC4090917
OpenAlexW2107994994

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.